Overview
Cerebral is a digital mental health company offering online access to licensed therapists, psychiatric prescribers, and care counselors for conditions including depression, anxiety, ADHD, and insomnia. Their subscription-based telehealth model has served millions of patients across the United States.
Cerebral is a digital mental health company headquartered in San Francisco, California, that provides online access to a comprehensive suite of mental health services through a subscription-based telehealth platform. The company connects patients with licensed therapists, psychiatric prescribers, and care counselors to address a range of conditions including depression, anxiety, ADHD, and insomnia. Their technology-driven model streamlines the patient intake process, enabling faster access to diagnosis, therapy, and medication management compared to traditional care pathways. By integrating clinical care with digital infrastructure, Cerebral reduces the friction that historically prevents individuals from seeking and maintaining mental health treatment.
Since its founding, Cerebral has grown to serve millions of patients across the United States, establishing itself as one of the largest telehealth mental health providers in the country. The company has raised $300 million in Series C funding, reflecting strong investor confidence in the scalability of its care delivery model. This capital has supported expansion of its clinical workforce, technology platform, and the breadth of conditions it addresses. Cerebral's growth trajectory places it among a small group of digital health companies that have achieved significant scale in the behavioral health space within a relatively short period.
Cerebral represents a meaningful development for the broader neurotechnology and mental health tech industry by demonstrating that scalable, technology-enabled mental health care is both clinically viable and commercially sustainable. The company bridges the gap between traditional psychiatric and therapeutic services and the growing demand for accessible, on-demand care, helping to normalize digital-first approaches to brain and behavioral health. As the industry increasingly looks to combine neurotechnology tools with clinical mental health services, companies like Cerebral establish the infrastructure and patient relationships that could support future integration of diagnostics, biomarkers, and neurologically informed care protocols. Their model serves as a reference point for how digital platforms can meaningfully expand access to mental health treatment at a population level.
More in Mental Health Tech
Latest industry news
Synchron Closes $275M Series D to Accelerate Stentrode BCI Commercialization
2026-06-15 ยท Funding
MIT Researchers Demonstrate Real-Time Emotion Decoding via Non-Invasive EEG with 94% Accuracy
2026-06-13 ยท Research
Synchron Launches Stentrode Home Edition, Expanding BCI Access Beyond Clinical Settings
2026-06-11 ยท Product
Synchron Reaches 100-Patient Milestone as Stentrode BCI Moves Toward Pivotal Trial
2026-06-09 ยท Industry
Company details
Category
๐ Mental Health Tech
Location
San Francisco, USA
Funding
Series C ยท $300M
Website
www.cerebral.comListed
2026-06-15
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages โ